15 devices · GMDN 57715
This category includes antibodies designed to detect the presence of ZAP-70, a protein involved in immune cell signaling, in patient samples such as blood or tissue. These reagents are used in laboratory settings to support the diagnosis and monitoring of certain lymphoid malignancies, particularly chronic lymphocytic leukemia, by helping assess ZAP-70 expression levels.
Devices in this category are in vitro diagnostic (IVD) antibodies that are regulated based on their intended use for detecting a specific biomarker. They are supplied as standalone reagents or as part of assay systems and are intended for use by trained professionals in clinical laboratories following appropriate validation and quality control procedures.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.